You have 9 free searches left this month | for more free features.

Condition

Migraine (2)

Healthy (1)

Overall Status

Not yet recruiting (2)

Completed (1)

Sign in for free

Phase

phase 1 (1)

phase 2/phase 3 (1)

phase 3 (1)

Sponsor

Pfizer (2)

Biohaven Pharmaceuticals, Inc. (1)

Collaborator

Intervention

zavegepant (3)

intranasal aptar pharma unit dose system (1)

placebo (1)

zavegepant matching placebo (1)

Study Documents

Intervention Type

drug (3)

device (1)

Funder Type

Industry (3)

Study Type

Interventional (3)

zavegepant

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Healthy Trial (Zavegepant)

Not yet recruiting

Healthy

Zavegepant

(no location specified)

Jul 16, 2023

Migraine Trial (Zavegepant, Placebo)

Not yet recruiting

Migraine

Zavegepant
Placebo

(no location specified)

Aug 3, 2023

Migraine Trial in United States (BHV3500 (zavegepant) 10mg, BHV3500 (zavegepant) 20mg, BHV3500 (zavegepant) 5mg)

Completed

Has Results

Migraine

Zavegepant
+2 more

Mobile, Alabama
+81 more

Dec 16, 2022